Opportunistic Muscle Density Assay During CT Lung Cancer Screening for Low Muscle Quality Evaluation in Older Adults: a Multicenter Study

Overview

Journal Aging Clin Exp Res

Publisher Springer

Specialty Geriatrics

Date 2025 Feb 22

PMID 39985725

Authors

Xin Chen

Xifa Gao

Rongzhou Wang

Zicheng Wei

Jiangchuan Wang

Miaomiao Wang

Chao Xie

Xiao Chen

Affiliations

Soon will be listed here.

Abstract

Background: Intramuscular adiposity, which can be reflected by muscle computed tomography (CT) attenuation, may be a marker of sarcopenia. This study aimed to investigate muscle attenuation across the life course and thresholds of muscle attenuation for evaluating low muscle quality in older adults.

Methods: This retrospective multicenter study included 9701 subjects aged 20 years and older who underwent CT lung cancer screening from 2019 to 2021 at our institutions in cohort 1. Muscle attenuation (Hounsfield units [HUs]) of the bilateral erector spinae and spleen attenuation at the middle level of the T11 vertebra were measured. The T score, which is analogous to that used to define osteoporosis, was calculated on the basis of absolute muscle attenuation and the muscle‒spleen ratio (M/S). A T score < -2.5 was used to define low muscle density. The cutoff points for muscle CT attenuation and M/S were subsequently calculated to define low muscle density. Another cohort (cohort 2) of 2006 subjects aged 50 years or older was included to explore the association between low muscle quality and vertebral compression fracture (VCF).

Results: The mean [SD] age of cohort 1 was 51.8 [15.5] years, and 5896 [60.8%] men were included. The mean [SD] age of cohort 2 was 62.4 [9.6] years, and 1162 [57.9%] men were included. Multiple linear regression analysis revealed that age was associated with muscle CT attenuation (β = -0.19, 95% confidence interval (CI): -0.21 to -0.18) and the M/S ratio (β = -0.004, 95% CI: -0.004 to -0.003). The prevalence of low muscle density was dependent on the cutoff point and increased with age. A cutoff point of 32 HU for women and 37 HU for men and an M/S of 0.65 for women and 0.75 for men were used to define low muscle density. Low muscle density defined by those cutoff points was associated with the risk of VCF [muscle attenuation: adjusted hazard ratio (aHR) = 0.422 (95% CI: 0.256-0.696) for women; aHR = 0.391 (95% CI: 0.173-0.883) for men; M/S: aHR = 0.40 (95% CI: 0.23-0.68) for women; aHR = 0.23 (95% CI: 0.09-0.58) for men].

Conclusion: Muscle density decreases with age. The muscle attenuation of 32 HU for women and 37 HU for men, an M/S of 0.65 for women and 0.75 for men, may be used to define low muscle density.

References

Dilloway T, Ashby D, Hickson M, Temple A, Johansson L . Handgrip Strength Index: A Novel Parameter Which Quantifies Clinical Weakness in People on Haemodialysis. J Ren Nutr. 2022; 33(3):456-464. DOI: 10.1053/j.jrn.2022.08.002. View

Cruz-Jentoft A, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T . Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2018; 48(1):16-31. PMC: 6322506. DOI: 10.1093/ageing/afy169. View

Kemper M, Molwitz I, Krause L, Reeh M, Burdelski C, Kluge S . Are muscle parameters obtained by computed tomography associated with outcome after esophagectomy for cancer?. Clin Nutr. 2021; 40(6):3729-3740. DOI: 10.1016/j.clnu.2021.04.040. View

Amini B, Boyle S, Boutin R, Lenchik L . Approaches to Assessment of Muscle Mass and Myosteatosis on Computed Tomography: A Systematic Review. J Gerontol A Biol Sci Med Sci. 2019; 74(10):1671-1678. PMC: 7357454. DOI: 10.1093/gerona/glz034. View

Gareen I, Gutman R, Sicks J, Tailor T, Hoffman R, Trivedi A . Significant Incidental Findings in the National Lung Screening Trial. JAMA Intern Med. 2023; 183(7):677-684. PMC: 10167600. DOI: 10.1001/jamainternmed.2023.1116. View

Falcon L, Harris-Love M . Sarcopenia and the New ICD-10-CM Code: Screening, Staging, and Diagnosis Considerations. Fed Pract. 2017; 34(7):24-32. PMC: 5576154. View

Rosenberg I . Sarcopenia: origins and clinical relevance. J Nutr. 1997; 127(5 Suppl):990S-991S. DOI: 10.1093/jn/127.5.990S. View

Chen L, Woo J, Assantachai P, Auyeung T, Chou M, Iijima K . Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020; 21(3):300-307.e2. DOI: 10.1016/j.jamda.2019.12.012. View

Orwoll E, Blackwell T, Cummings S, Cauley J, Lane N, Hoffman A . CT Muscle Density, D3Cr Muscle Mass, and Body Fat Associations With Physical Performance, Mobility Outcomes, and Mortality Risk in Older Men. J Gerontol A Biol Sci Med Sci. 2021; 77(4):790-799. PMC: 8974337. DOI: 10.1093/gerona/glab266. View

10.

ODowd E, Tietzova I, Bartlett E, Devaraj A, Biederer J, Brambilla M . ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer. Eur Respir J. 2023; 62(4). DOI: 10.1183/13993003.00533-2023. View

11.

Oba H, Matsui Y, Arai H, Watanabe T, Iida H, Mizuno T . Evaluation of muscle quality and quantity for the assessment of sarcopenia using mid-thigh computed tomography: a cohort study. BMC Geriatr. 2021; 21(1):239. PMC: 8045267. DOI: 10.1186/s12877-021-02187-w. View

12.

Fumagalli I, Le S, Peng P, Kipnis P, Liu V, Caan B . Automated CT Analysis of Body Composition as a Frailty Biomarker in Abdominal Surgery. JAMA Surg. 2024; 159(7):766-774. PMC: 11007659. DOI: 10.1001/jamasurg.2024.0628. View

13.

Chen L, Liu L, Woo J, Assantachai P, Auyeung T, Bahyah K . Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014; 15(2):95-101. DOI: 10.1016/j.jamda.2013.11.025. View

14.

Bahat G, Yilmaz O, Kilic C, Oren M, Karan M . Performance of SARC-F in Regard to Sarcopenia Definitions, Muscle Mass and Functional Measures. J Nutr Health Aging. 2018; 22(8):898-903. DOI: 10.1007/s12603-018-1067-8. View

15.

Genant H, Wu C, van Kuijk C, Nevitt M . Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993; 8(9):1137-48. DOI: 10.1002/jbmr.5650080915. View

16.

Kirk B, Harrison S, Zanker J, Burghardt A, Orwoll E, Duque G . Interactions Between HR-pQCT Bone Density and D Cr Muscle Mass (or HR-pQCT Bone Structure and HR-pQCT Muscle Density) in Predicting Fractures: The Osteoporotic Fractures in Men Study. J Bone Miner Res. 2023; 38(9):1245-1257. PMC: 10528106. DOI: 10.1002/jbmr.4874. View

17.

Tanoue L, Sather P, Cortopassi I, Dicks D, Curtis A, Michaud G . Standardizing the Reporting of Incidental, Non-Lung Cancer (Category S) Findings Identified on Lung Cancer Screening Low-Dose CT Imaging. Chest. 2022; 161(6):1697-1706. DOI: 10.1016/j.chest.2021.12.662. View

18.

Lenchik L, Lenoir K, Tan J, Boutin R, Callahan K, Kritchevsky S . Opportunistic Measurement of Skeletal Muscle Size and Muscle Attenuation on Computed Tomography Predicts 1-Year Mortality in Medicare Patients. J Gerontol A Biol Sci Med Sci. 2018; 74(7):1063-1069. PMC: 6765059. DOI: 10.1093/gerona/gly183. View

19.

Wang M, Tang H, Chen X, Liu J, Hu N, Cui W . Opportunistic Muscle Evaluation During Chest CT Is Associated With Vertebral Compression Fractures in Old Adults: A Longitudinal Study. J Gerontol A Biol Sci Med Sci. 2023; 79(2). DOI: 10.1093/gerona/glad162. View

20.

Cruz-Jentoft A, Sayer A . Sarcopenia. Lancet. 2019; 393(10191):2636-2646. DOI: 10.1016/S0140-6736(19)31138-9. View